- Δεν είναι ανάγκη ένα paper να είναι δυσνόητο!!! https://www.nejm.org/doi/full/10.1056/NEJMoa2200674 8 comments greece
Linked pages
- FDA Approves First COVID-19 Vaccine | FDA https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine 1425 comments
- CDC COVID Data Tracker https://covid.cdc.gov/covid-data-tracker/#trends_dailycases 531 comments
- Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208375 145 comments
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months | NEJM https://www.nejm.org/doi/10.1056/nejmoa2114583 58 comments
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2108891 50 comments
- FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age | FDA https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age 7 comments
- Waning Immunity after the BNT162b2 Vaccine in Israel | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2114228 0 comments
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2114114 0 comments
Related searches:
Search whole site: site:doi.org
Search title: Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM
See how to search.